Loading clinical trials...
Loading clinical trials...
Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children With Crohn's Disease
Conditions
Locations
28
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
UCLA Medical Center
Los Angeles, California, United States
University of California at San Francisco
San Francisco, California, United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
Nemours Children's Clinic
Jacksonville, Florida, United States
Emory-Children's Center - Emory University School of Medicine
Atlanta, Georgia, United States
Start Date
November 1, 2008
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2020
Last Updated
November 16, 2021
NCT06226883
NCT07184931
NCT06918808
NCT06647615
NCT07383844
NCT07385131
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions